World first as drug developed using AI enters clinical trials

This may just be the first drug to be generated using artificial intelligence (AI) which has now entered clinical trials in Japan.

“The project has been particularly heralded for the speed it took to complete – taking just 12 months when compared to the typical five years it takes drug companies to complete the research phase. For instance, the candidate compound for the drug was found within 350 synthesised compounds, compared to the usual 2,500 compounds it takes drug companies to discover a novel compound.”

Microsoft takes the wraps off $40 million, five-year ‘AI for Health’ initiative

Microsoft has recently announced a $40 Million investment in AI for Health Initiatives.

“Through its AI for Good projects, Microsoft is applying lessons from software to artificial intelligence technologies that are under development. In the case of health, Microsoft officials said their mission is to use insights derived from AI technologies and techniques to search for cures for diseases that plague humanity.”

A single number helps Stanford data scientists find most dangerous cancer cells

“Biomedical data scientists at the Stanford University School of Medicine have shown that the number of genes a cell uses to make RNA is a reliable indicator of how developed the cell is, a finding that could make it easier to target cancer-causing genes.“